William Shatner Anjali Sundaram | CNBC Science fiction will soon become reality, as William Shatner is scheduled to launch on the next crewed spaceflight of Jeff Bezos’ Blue Origin. Blue Origin plans to fly the Canadian actor, who famously played Captain Kirk in the original Star Trek television series, as one of the passengers on
What are your options if you inherit an annuity? Annuities are financial products that are paid for upfront, then pay out a set amount for a period of time, sometimes until death. They are sometimes used by retirees to secure a reliable income in retirement. Some annuities payments can be left to a beneficiary after
In this article FB DD UNP F Facebook’s logo displayed on a phone screen. Jakub Porzycki | NurPhoto via Getty Images Check out the companies making headlines in midday trading. Facebook — Facebook shares fell 5.5% after a company whistleblower unveiled her identify and accused the social media giant of a “betrayal of democracy.” The
ViacomCBS (NASDAQ:VIAC) has been a costly disappointment for some investors in 2021. Enthusiasm over the company’s newly-announced streaming plans paired with Reddit-fueled retail investors drove VIAC stock past $100 three weeks into March. That was a 174% gain in under four months. Source: Jer123 / Shutterstock.com A catastrophic crash then saw shares lose half their
A bit of positive news included in Carnival’s (NYSE:CCL) second-quarter results lifted CCL stock in late September. But even as the world appears on track to get “back to normal,” you may not want to buy Carnival’s shares at its present levels. There’s a good chance that the cruise line operator’s results will fully bounce
Recently, Novavax (NASDAQ:NVAX) fell fast. Closing at $207.31 per share on Sept. 30, the vaccine play opened at around $190 on Oct. 1. After that, NVAX stock quickly went into free fall, dropping as low as $154 per share. Source: Ascannio/Shutterstock.com The reason? Breaking news of Merck’s (NYSE:MRK) antiviral Covid-19 pill. Interim results suggest it
Dear MarketWatch, My mother moved to an apartment from her house in 2014 and started using the house as rental property. She bought it with my father in the 60s, and she bought part of it from him after they divorced in the 70s. I don’t know if I have documentation of any costs, but
Engine No. 1, the firm that rose to prominence after waging a successful campaign against Exxon, on Monday announced an investment in General Motors. This time, the upstart activist’s stake signals support for the automaker as it transitions to electric vehicles. Engine No. 1 pointed to the similarities between Exxon and GM, noting that each
On today’s show, Preston and Stig talk about the current market conditions and how they are positioning their portfolio. In the second half of the show, they talk about previous mastermind picks and how they have performed when compared to the S&P500. IN THIS EPISODE, YOU’LL LEARN: – How Preston and Stig’s previous stock picks
I’ve got a question for you. How many shares are you trading currently on per trade basis? How do you decide that? Well, there’s a lot of people out there that wonder exactly this “How many shares should they trade” Should I trade 2 percent of my account size? Or just always trade 100 shares
Hey everybody, Dave Bartosiak with Trending Stocks for Zacks.com. Roku is nearing a distribution deal with AT&T for HBO Max. Not to be confused with Boeing’s Death Trap that is the 737 MAX nor HBO GO nor HBO Now. It’s HBO’s standalone streaming service that will set you back $15 a month. Rumors about a
The percentage of rich people in America has risen substantially over the past several years, and many of these individuals are turning to donor-advised funds (DAFs) to assist with their charitable efforts. At the end of 2020, according to the Credit Suisse Global Wealth Report, 21.9 million individuals with a net worth of $1 million or greater, excluding
Hyliion Holdings (NYSE:HYLN) has been a painful investment for many. A year ago, it shares were was trading as high as $55 a piece. Yet its been downhill ever since. I cautioned in March that a HYLN stock investment would require patience. Source: Hyliion media The stock is down nearly 50% since that call. Despite
A year ago, electric vehicles (EVs) were a promising sector for investors. But in 2021, that all changed. Sponsors of special purpose acquisition companies (SPACs) flooded the market with new EV stock investments. Some of these, like Lucid Motors (NASDAQ:LCID), have worked out pretty well. Most, however, have been terrible for investors. Unfortunately, Lordstown Motors
Have you been keeping an eye on the developments in the genetic editing space? We have. Source: Shutterstock And recently, CRISPR gene editing pioneer Feng Zhang achieved a breakthrough in CRISPR therapy cell-delivery. Instead of using the “default” Cas9 enzyme, Zhang used a sub-family of the Cas13 enzyme. One that’s just tiny enough to fit
Another day, another trading scandal? This time the focus is on Vice Chair Richard Clarida. Citing financial disclosure forms, Bloomberg News reported he shifted funds from a Pimco bond fund into two stock-market funds — a day ahead of a statement from Chair Jerome Powell about possible policy action as the pandemic worsened. Clarida’s trades
For those who write out checks regularly, the process becomes almost automatic. However, if you haven’t written many checks, it can be confusing. Checks are being superseded by electronic transfers, but they aren’t obsolete yet. Here are the steps needed to know how to fill out a check and explain the numbers preprinted on each one.
Here’s a rare opportunity for you. A “next-generation Medicare Advantage insurer,” Clover Health (NASDAQ:CLOV) operates in a high-potential market, providing health care access to seniors and other patient demographics. Yet, CLOV stock is trading at a surprisingly low price. Source: Shutterstock Currently, this stock has landed gently at a strong support level. So, it might be
With the seemingly worsening crisis of property developer China Evergrande (OTCMKTS:EGRNF), it may be time for investors to at least consider reducing exposure to companies tied to the world’s second-largest economy. Late last week, the Wall Street Journal reported that Evergrande failed to make a scheduled interest payment last Thursday, sparking concerns about a mass
After rising over $100 briefly this year, Cassava Sciences (NASDAQ:SAVA) stock is struggling to rebound. A long document written by the lawyer of a short-seller sent SAVA stock lower. The document challenged the accuracy of some of Cassava’s clinical results Source: Atthapon Raksthaput / Shutterstock.com Cassava has two major clinical studies underway. The top-line data